Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy.

OBJECTIVE

To evaluate patient satisfaction with pharmacist-administered long-acting injectable antipsychotics (LAIAs) in the community pharmacy.

DESIGN

Prospective survey.

SETTING

Albertsons Companies community pharmacies during December 2016 to February 2017.

PARTICIPANTS

Patients receiving LAIAs at participating pharmacies.

MAIN OUTCOME MEASURES: A survey assessed patients' satisfaction with pharmacist-administered LAIAs in the community pharmacy.

RESULTS

LAIA recipients (N = 104) reported satisfaction with community pharmacist-administered LAIAs. Participants who had received the service at other types of health clinics (N = 57) also reported higher satisfaction with current service compared to a similar service received elsewhere. Participants indicated that they would recommend service to others and that service was more convenient than a similar service received in an alternative setting. There was not a statistically significant relationship between patient demographic characteristics and likelihood of recommending service to others.

CONCLUSION

Patients were satisfied with a pharmacist-administered LAIA service in the community pharmacy, and they found it more convenient than similar services provided elsewhere.